Clal Biotechnology Industries Ltd. (TASE:CBI) announced that it has entered into an investment agreement for private placement of 6,758,583 common shares at ILS 3.699 per share for gross proceeds of ILS 24,999,999 million on July 11, 2017. The transaction include participation from Meitav Dash Providence and Pension Ltd. for stake of 4.32%. Post this transaction the investor's total stake will be 5.32%. The company will also issue 4,460,665 unlisted warrants in the transaction. The 4,460,665 warrants are exercisable into the Company's 4,460,665 ordinary shares; which can be exercised up until 27 months from the date of allocation. Each warrant is exercisable at ILS 4 for within 18 months and at ILS 4 per share after first 18 months. The securities are subject to hold period of six months since allotment. The allotment of the shares is subject to Tel-Aviv Stock Exchange approval for the listing.